FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

371611000001106: DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16629901000001111 DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
16630001000001117 DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Is a Product containing precisely desmopressin acetate 200 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has active ingredient Desmopressin acetate false Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Is a DDAVP false Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has specific active ingredient Desmopressin acetate true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) 90 tablet Is pack of False DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) 90 tablet Has AMP True DDAVP 0.2mg tablets (Ferring Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start